<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main"></title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">22C29FF6A244449F878AED4F0A123090</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-23T17:32+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>The change of the lattice parameters, evaluated by the shift of the diffraction peak with respect to pure calcite, and the broadening of the diffraction peaks, were used as tool evaluate the incorporation of the drug in the calcite crystal lattice. Moreover, a thermal treatment was applied to pyrolyse the entrapped drug. After this treatment the change in the crystal lattice was removed, going back to the one of pure calcite and further proving the presence of drug in the crystalline lattice (Figure <ref type="figure" target="#fig_1">3</ref>). The Table <ref type="table">1</ref> summarizes the results of the diffraction experiments showing fro which drug a change of the lattice parameter with respect to calcite was observed.</p><p>Table <ref type="table">1</ref>. Summary on the entrapment of diverse drugs in the crystal lattice of calcite.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Drug</head><p>Entrapment in the crystal lattice</p><formula xml:id="formula_0">Doxorubicin √ Minocilin √ Retinoic acid X Dichloro acetic acid X Camptotecin X Ibuprofen √ Fenacetin X</formula><p>In conclusion the X-ray diffraction experiment at ID22 showed that doxorubicin, minociclin and ibuprofen are incorporated in the crystal lattice of caclite.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 2 .</head><label>2</label><figDesc>Figure 2. Optical microscope images. Change in the morphology, aggregation and density of precipitation of CaCO 3 crystals as function of the concentration of the drug. A similar trend was observed for all the drugs used (here doxorubicin). The average size of the crystals was about 50 µm. The incorporation of the drug in the crystal lattice of calcite was evaluate by High Resolution X-ray Powder Diffraction Experiment at the ID22 beam line of ESRF.The change of the lattice parameters, evaluated by the shift of the diffraction peak with respect to pure calcite, and the broadening of the diffraction peaks, were used as tool evaluate the incorporation of the drug in the calcite crystal lattice. Moreover, a thermal treatment was applied to pyrolyse the entrapped drug. After this treatment the change in the crystal lattice was removed, going back to the one of pure calcite and further proving the presence of drug in the crystalline lattice (Figure3).</figDesc><graphic coords="2,147.62,268.58,304.32,179.52" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 3 .</head><label>3</label><figDesc>Figure 3. HRXRD profile of the {10.4} peak of calcite crystals grew in the presence of 5 mM doxorubicin. The shifht of the peak is removed after annealing, proving the presence of the drug in the crystal lattice.</figDesc></figure>
		</body>
		<back>
			<div type="references">

				<listBibl/>
			</div>
		</back>
	</text>
</TEI>
